Cancer Immunotherapy and Biological Cancer Treatments (Record no. 68861)

MARC details
000 -LEADER
fixed length control field 02069naaaa2200313uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/67089
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220220054905.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number intechopen.77856
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789848632
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789848625
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789843668
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5772/intechopen.77856
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Arnouk, Hilal
Relationship edt
245 10 - TITLE STATEMENT
Title Cancer Immunotherapy and Biological Cancer Treatments
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. IntechOpen
Date of publication, distribution, etc. 2019
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (112 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. In recent years, biological cancer therapies, including immunotherapy, have moved from the bench to mainstream medical treatments of several types of cancer. The success of these treatments relies on innovative approaches to specifically interfere with molecular targets that are involved in the growth, progression, and spread of malignant cells, or to bypass the tumor evasion of the immune system utilizing the latest advances in cancer vaccine development, formulation, and delivery. This book presents an up-to-date overview of novel cancer biological and immunotherapeutic approaches, including cancer vaccines, mimetic vaccines, monoclonal antibodies, adoptive T-cell transfer, chimeric antigen receptor T- cells, tumor infiltrating lymphocytes, dendritic cells, natural killer cells, immune checkpoint inhibitors, laser ablation, and immune stimulating interstitial laser thermotherapy.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
Use and reproduction rights https://creativecommons.org/licenses/by/3.0/
Source of term cc
-- https://creativecommons.org/licenses/by/3.0/
546 ## - LANGUAGE NOTE
Language note English
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology
Source of heading or term bicssc
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Oncology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arnouk, Hilal
Relationship oth
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://mts.intechopen.com/storage/books/8025/authors_book/authors_book.pdf">https://mts.intechopen.com/storage/books/8025/authors_book/authors_book.pdf</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/67089">https://directory.doabooks.org/handle/20.500.12854/67089</a>
Access status 0
Public note DOAB: description of the publication

No items available.